394 related articles for article (PubMed ID: 12706893)
1. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.
Walsh NC; Cahill M; Carninci P; Kawai J; Okazaki Y; Hayashizaki Y; Hume DA; Cassady AI
Gene; 2003 Mar; 307():111-23. PubMed ID: 12706893
[TBL] [Abstract][Full Text] [Related]
2. Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice.
Pan W; Mathews W; Donohue JM; Ramnaraine ML; Lynch C; Selski DJ; Walsh N; Cassady AI; Clohisy DR
J Biol Chem; 2005 Feb; 280(6):4888-93. PubMed ID: 15590658
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed three non-coding alternate exons at 5' UTR of regulatory type I beta subunit gene of mouse.
Banday AR; Azim S; Tabish M
Mol Biol Rep; 2012 Apr; 39(4):3375-83. PubMed ID: 21706350
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
[TBL] [Abstract][Full Text] [Related]
5. Structure and expression of the mouse growth hormone receptor/growth hormone binding protein gene.
Moffat JG; Edens A; Talamantes F
J Mol Endocrinol; 1999 Aug; 23(1):33-44. PubMed ID: 10425445
[TBL] [Abstract][Full Text] [Related]
6. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter.
Reddy SV; Hundley JE; Windle JJ; Alcantara O; Linn R; Leach RJ; Boldt DH; Roodman GD
J Bone Miner Res; 1995 Apr; 10(4):601-6. PubMed ID: 7610931
[TBL] [Abstract][Full Text] [Related]
8. Genomic organization and alternative transcripts of the human Connexin40 gene.
Dupays L; Mazurais D; Rücker-Martin C; Calmels T; Bernot D; Cronier L; Malassiné A; Gros D; Théveniau-Ruissy M
Gene; 2003 Feb; 305(1):79-90. PubMed ID: 12594044
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5' end heterogeneity.
Tolner B; Roy K; Sirotnak FM
Gene; 1998 May; 211(2):331-41. PubMed ID: 9602167
[TBL] [Abstract][Full Text] [Related]
10. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 5'-flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene.
Reddy SV; Kuzhandaivelu N; Acosta LG; Roodman GD
Bone; 1995 May; 16(5):587-93. PubMed ID: 7654474
[TBL] [Abstract][Full Text] [Related]
12. Structure of the 5' region of the Hst70 gene transcription unit: presence of an intron and multiple transcription initiation sites.
Scieglinska D; Widłak W; Konopka W; Poutanen M; Rahman N; Huhtaniemi I; Krawczyk Z
Biochem J; 2001 Oct; 359(Pt 1):129-37. PubMed ID: 11563976
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization and differential splicing of the mouse and human Pcyt2 genes.
Poloumienko A; Coté A; Quee AT; Zhu L; Bakovic M
Gene; 2004 Jan; 325():145-55. PubMed ID: 14697519
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters.
Chen J; Randeva HS
Biochem J; 2010 Apr; 427(3):377-90. PubMed ID: 20156195
[TBL] [Abstract][Full Text] [Related]
15. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing.
George CX; Wagner MV; Samuel CE
J Biol Chem; 2005 Apr; 280(15):15020-8. PubMed ID: 15677478
[TBL] [Abstract][Full Text] [Related]
16. Transcription from the tartrate-resistant acid phosphatase promoter is negatively regulated by the Myc oncoprotein.
Daumer KM; Taparowsky EJ; Hall DJ; Steinbeck MJ
J Bone Miner Res; 2002 Sep; 17(9):1701-9. PubMed ID: 12211441
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene.
Reddy SV; Scarcez T; Windle JJ; Leach RJ; Hundley JE; Chirgwin JM; Chou JY; Roodman GD
J Bone Miner Res; 1993 Oct; 8(10):1263-70. PubMed ID: 8256664
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover.
Angel NZ; Walsh N; Forwood MR; Ostrowski MC; Cassady AI; Hume DA
J Bone Miner Res; 2000 Jan; 15(1):103-10. PubMed ID: 10646119
[TBL] [Abstract][Full Text] [Related]
19. Cloning, gene organization and identification of an alternative splicing process in lecithin:retinol acyltransferase cDNA from human liver.
Zolfaghari R; Ross AC
Gene; 2004 Oct; 341():181-8. PubMed ID: 15474300
[TBL] [Abstract][Full Text] [Related]
20. Structure of the murine Pit1 phosphate transporter/retrovirus receptor gene and functional characterization of its promoter region.
Palmer G; Manen D; Bonjour J; Caverzasio J
Gene; 2000 Feb; 244(1-2):35-45. PubMed ID: 10689185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
